[ Price : $8.95]
Sen. Tim Scott and Rep. Earl Carter say a recent FDA guidance on advanced manufacturing technologies for drugs does not match cong...[ Price : $8.95]
Federal Register notice: FDA amends its standing advisory committee regulations to add the 12/13/2023 establishment of the Genetic...[ Price : $8.95]
FDA extends by three months its review on a Zevra Therapeutics NDA resubmission for arimoclomol, an investigational oral treatment...[ Price : $8.95]
FDA approves Hugels Letybo (botulinum toxin), a neurotoxin for treating moderate-to-severe glabellar (frown) lines in adults.[ Price : $8.95]
Federal Register notice: FDA announces a 5/16 Vaccines and Related Biological Products Advisory Committee meeting to discuss the s...[ Price : $8.95]
FDA removes a partial clinical hold on Iovance Biotherapeutics IOV-LUN-202 trial investigating the companys LN-145 TIL cell therap...[ Price : $8.95]
SpringWorks Therapeutics commences a rolling NDA for mirdametinib, an investigational MEK inhibitor for treating pediatric and adu...[ Price : $8.95]
CBER cites Oregon Medical Centers in an untitled letter over claims it is making on social media sites Facebook and Youtube about ...